Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
71,550.73
(
-2.09%
)
News Focus
News Focus
Post# of 30990
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: None

Thursday, 09/22/2016 11:57:09 AM

Thursday, September 22, 2016 11:57:09 AM

Post# of 30990
A reading of the planning for commercializing Nilvadapine for the treatment of Alzheimer's demonstrates the seriousness of the NILVAD project and describes its intention to proceed with 2nd generation meds developed by Archer, which I believe includes anatabine.

http://www.nilvad.eu/the-project/wp08-exploitation-and-scientific-direction/
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today